Recipharm Investments

Recipharm has invested in 4 companies and its latest investment was NewBiologix on May 10, 2023

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

NewBiologix is a Switzerland-based DNA integration platform that focuses on engineering cell lines used to manufacture gene and cell therapies.
$50M
May 10, 2023
-
LIDDS engages in researching and developing medicines and drugs for the treatment of prostate cancer.
$500K
Dec 16, 2015
-
Palette is a Sweden-based biotechnology company that researches and develops novel therapies for the treatment of cancer and urinal disorders.
$3.3M
Jul 08, 2015
-
Synthonics is a pharmaceutical firm focused on novel drug discovery and development. 
-
Apr 13, 2015
-

Frequently Asked Questions about Recipharm

  1. What is Recipharm investing in?

    Recipharm has invested in 4 companies including NewBiologix, Liddspharma and Palette Life
  2. What company did Recipharm invest in?

    Recipharm invested in a total 4 companies including NewBiologix, Liddspharma and Palette Life
  1. What are the top 4 investments by Recipharm?

    The top companies in which Recipharm invested are NewBiologix, Liddspharma, Palette Life and Synthonics